Riyadh — Mubasher: The board of Wajd Life Trading Company approved the activation of its general medical complex activity on 15 October 2026.

The decision aligns with the company’s articles of association and commercial registration, aiming to diversify income sources by leveraging its existing expertise within the healthcare sector.

The company stated that the current phase involves updating and completing a feasibility study to evaluate investment and operational alternatives.

At this stage, Wajd Life has not finalized the location of the complex, the implementation mechanism, or the total investment costs and financing requirements.

A specific operational timeline will be established following the conclusion of these technical studies and the acquisition of necessary regulatory approvals.

Wajd Life noted that the expected financial impact cannot be determined at this time due to the ongoing evaluation of investment alternatives.

The company committed to disclosing further material developments regarding the project’s costs and financing requirements once the studies are finalized and official licenses are obtained from the relevant authorities.

At the end of June 2026, the company recorded earnings of SAR 3.96 million, an annual hike of 95.26% from SAR 2.03 million.